The CEO of Bioviva USA Inc., Elizabeth Parrish, became the first person to undergo rejuvenative gene therapy in 2015, and results are now out – the procedure successfully lengthened her telomeres by the equivalent of 20 years.
Changing disease through genetic therapies. We work on anti aging / age reversing gene therapies to mitigate the diseases of old age. BioViva Sciences - the cure is the the Helix of Humanity.
We are gene therapy innovation leaders. We develop platforms
to treat severe genetic disorders and cellular aging.
Seattle WA©2022. BioViva All rights reserved | For any inquires, contact info@bioviva-science.com
facebook
twitter
instagram
linkedin
youtube